Most patients trust their doctors and most doctors (in my experience) are trustworthy, in fact I married one. Unfortunately, not all doctors have the patient’s best interests at heart when it conflicts with their bottom line. The New York Times recently published an article revealing that many patients suffering from peripheral artery disease underwent sometimes…
Tepezza, also known as teprotumumab-trbw, is a new biologic drug therapy used to treat adults with active thyroid eye disease (TED). TED is an autoimmune disorder that causes the muscles and fatty tissues around the eyes to become inflamed, resulting in bulging eyes, double vision, and other vision problems. Tepezza is administered intravenously (IV) by…
The California-based pharmaceutical company Gilead Sciences, Inc. is being sued by dozens of HIV/AIDS patients who claim the company stalled the development of a safer drug in its own laboratory for the sole purpose of maximizing profits. Lawsuits claim Gilead put profits over safety The plaintiffs are seeking to hold Gilead accountable for…
Since the first hip replacement was performed in 1960, patients have been relying on this operation to restore their mobility and independence. Hip replacement surgeries have become increasingly popular over the years, with more patients getting implants at a younger age. In fact, more than 300,000 of these surgeries are performed each year in the…
The US Food and Drug Administration issued a December 2018 warning that taking FLQs (fluoroquinolones antibiotics) puts patients at a higher risk of ruptures or tears in the aorta. According to the FDA’s analysis of adverse events, the risk of aortic aneurysm in the general FLQ-using population is nine per 100,000. However, in high risk…
There is promising news for the more than 4 million patients who take Xarelto® (Riviaroxaban) or Eliquis® (Aixaban) on a daily basis. These blood thinners, while effective, have been shown to cause uncontrolled and sometimes life-threatening bleeding events. The FDA has finally approved a reversal agent that can stop the anticoagulant effects of Xa inhibitors, in the form…